ArticleNature communications2025

Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo.

Liam Kempthorne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.